Weekly Recap: 58% revenue rise and 150,000+ seeds produced
Cronos Group Inc (NASDAQ:CRON) posted 58% revenue growth year-over-year and six straight quarters of positive adjusted EBITDA since Q1 2025 while sitting on CAD 827 million cash and no debt, even as management flags regulatory risks; its advanced genetics program has produced 150,000+ seeds and 20…